Clinical Trials Browser

Not yet recruiting × Carcinoma, Non-Small-Cell Lung × 130-nm albumin-bound paclitaxel × Clear all

NCT07618793 2026-06-01

Intermittent Hypoxic Training as Neoadjuvant Therapy for Lung Squamous Cell Carcinoma

Phase 2 Not yet recruiting

Pathologic Complete Response, Carcinoma, Carcinoma, Non-Small-Cell Lung

NCT07524257 2026-05-04

Phase 3 Study of Nogapendekin Alfa Inbakicept Plus Standard of Care vs Standard of Care in First-Line Advanced or Metastatic NSCLC

Phase 3 Not yet recruiting

Carcinoma, Non-Small-Cell Lung

NCT07200947 2025-10-01

QL1706

Phase 2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung

NCT06604351 2024-09-19

Example

Phase 2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung

NCT06299371 2024-03-07

Adebrelimab Plus Chemotherapy as Neoadjuvant Therapy in Resectable NSCLC Harboring Driver Gene Mutations

Phase 2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung

NCT06109402 2023-12-19

Perioperative Immunotherpay Versus Adjuvant Immunotherapy for Resectable Non-small Cell Lung Cancer

Phase 2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung

NCT05891080 2023-06-06

Neoadjuvant Therapy With Toripalimab and JS004 Combined With Platinum-based Doublet Chemotherapy for Resectable or Potentially Resectable Stage III Non-small Cell Lung Cancer: A Randomised Controlled, Open-label, Phase 2 Trial

Phase 2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung